Eleven genes linked to Alzheimer's

Share this article:

Eleven newly identified genes are associated with Alzheimer's Disease, reports the National Institutes of Health (NIH). The government agency said in a statement on Monday that these genetic fingerprints could help researchers find new ways to attack the mind-destroying disease, which affects more than 5 million in the US.

What triggers the disease still eludes researchers, but concern about the condition's impact continues to soar. The Alzheimer's Association projects that 7.1 million people 65 and older will have Alzheimer's in 10 years. This is a 40% increase from the 5.1 million who now have the disease, and the total is expected to jump to between 14 million and 16 million by 2050. On the financial side, the association noted that caregivers, who provide aid such as getting into and out of bed, feeding, dressing, bathing and managing incontinence, provided $216.4 billion in unpaid care in 2012.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.